Worldwide, breast cancer is the leading cause of cancer-related deaths in women. Breast
cancer is a heterogeneous disease characterized by different clinical outcomes in terms of …

In the era of quantitative proteomics, where mass spectrometry plays a pivotal role, in
particular associated with the use of data‐independent acquisition, it is time to perform an …

The possibility to record proteomes in high throughput and at high quality has opened new
avenues for biomedical research, drug discovery, systems biology, and clinical translation …

Breast cancer (BC) is characterized by an extensive genotypic and phenotypic
heterogeneity. In-depth investigations into the molecular bases of BC phenotypes …

Cancer is a heterogeneous multifactorial disease, which continues to be one of the main
causes of death worldwide. Despite the extensive efforts for establishing accurate diagnostic …

Immunohistochemistry (IHC) is still widely used as a morphology-based assay for in situ
analysis of target proteins as specific tumor antigens. However, as a very heterogeneous …

Disease biomarkers are the measurable changes associated with a pathophysiological
process. Without homeostatic control, urine accumulates systematic changes in the body …

In this study, a novel and sensitive electrochemical aptasensing platform was fabricated for
the detection of the breast cancer biomarker HER2. HER2 aptamer was firstly hybridized …

Breast cancer is an individually unique, multi-faceted and chameleonic disease, an eternal
challenge for the new era of high-integrated precision diagnostic and personalized …

Prostate cancer (CaP) is the most common cancer in men and the second leading cause of
cancer deaths in males in Australia. Although serum prostate-specific antigen (PSA) has …